| scholarly article | Q13442814 |
| P50 | author | Robbert J Kok | Q88979280 |
| P2093 | author name string | Michiel L Bots | |
| Menso J Nubé | |||
| Peter J Blankestijn | |||
| Roel Goldschmeding | |||
| Marinus A van den Dorpel | |||
| Claire H den Hoedt | |||
| Karin G F Gerritsen | |||
| Maaike K van Gelder | |||
| Muriel P Grooteman | |||
| P2860 | cites work | EBPG guideline on nutrition | Q80346328 |
| Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis | Q81284729 | ||
| Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration | Q82182089 | ||
| CCN2 (CTGF) gene polymorphism is a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients | Q82433082 | ||
| Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease | Q84409384 | ||
| CTGF/CCN2 is an autocrine regulator of cardiac fibrosis | Q90443624 | ||
| Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error | Q28259333 | ||
| Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis | Q28586772 | ||
| Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro | Q33212781 | ||
| Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). | Q35194509 | ||
| Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function | Q35206257 | ||
| Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes | Q35982374 | ||
| The importance of residual renal function in dialysis patients | Q36448288 | ||
| Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes. | Q36661077 | ||
| Connective tissue growth factor and cardiac fibrosis | Q37336945 | ||
| Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis | Q37877254 | ||
| Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis | Q37896399 | ||
| Connective tissue growth factor (CCN2) in blood vessels | Q38079105 | ||
| CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. | Q39855226 | ||
| Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation | Q40429853 | ||
| The Effect of cAMP-PKA Activation on TGF-β1-Induced Profibrotic Signaling | Q40706165 | ||
| Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis | Q44571611 | ||
| Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy | Q44617933 | ||
| Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats | Q44792728 | ||
| Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy | Q44865662 | ||
| Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients | Q46568515 | ||
| Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure | Q46705065 | ||
| Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study | Q46871140 | ||
| CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD). | Q47616685 | ||
| Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis | Q48235274 | ||
| Plasma CTGF is independently related to an increased risk of cardiovascular events and mortality in patients with atherosclerotic disease: the SMART study | Q48492207 | ||
| Connective tissue growth factor (CTGF) from basics to clinics. | Q53698795 | ||
| Anti-connective tissue growth factor detects and reduces plaque inflammation in early-stage carotid atherosclerotic lesions. | Q54021056 | ||
| Altered Hippo signalling in polycystic kidney disease. | Q54607031 | ||
| Effect of GFR on Plasma N-Terminal Connective Tissue Growth Factor (CTGF) Concentrations | Q58423182 | ||
| Involvement of Connective Tissue Growth Factor in Human and Experimental Hypertensive Nephrosclerosis | Q58423193 | ||
| Connective Tissue Growth Factor Is Associated With a Stable Atherosclerotic Plaque Phenotype and Is Involved in Plaque Stabilization After Stroke | Q58423195 | ||
| Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion | Q58423196 | ||
| Endothelial Cell Mineralocorticoid Receptors Regulate Deoxycorticosterone/Salt-Mediated Cardiac Remodeling and Vascular Reactivity But Not Blood Pressure | Q58433396 | ||
| Rebound kinetics of beta2-microglobulin after hemodialysis | Q73036652 | ||
| Expression of connective tissue growth factor in human renal fibrosis | Q74462450 | ||
| Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment | Q74667354 | ||
| Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats | Q77926991 | ||
| ??? | Q24811300 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hemodiafiltration | Q3144940 |
| connective tissue | Q25615 | ||
| hemodialysis patient | Q126109077 | ||
| P577 | publication date | 2019-05-13 | |
| P1433 | published in | Toxins | Q15724569 |
| P1476 | title | Connective Tissue Growth Factor Is Related to All-cause Mortality in Hemodialysis Patients and Is Lowered by On-line Hemodiafiltration: Results from the Convective Transport Study | |
| P478 | volume | 11 |
Search more.